Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital fibrinogen concentrate for acute traumatic haemorrhage
ACTRN12626001300369Phase 2Recruiting
- Sponsor
- NSW Ambulance
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of Fibrinogen human in Bleeding (2 arms), sponsored by NSW Ambulance. Primary endpoint: Percentage of patients with fibrinogen level greater than 2.0 g/L. Started Sep 2024; status: recruiting.
02
Drugs
Fibrinogen human
03
Conditions
Bleeding
Beyond the preview
Go deeper on ACTRN12626001300369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626001300369.